• Profile
Close

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

World Journal of Urology Nov 28, 2019

Kind S, Büscheck F, Höflmayer D, et al. - A tissue microarray comprising samples of 17,747 tumors with annotated clinicopathological and molecular data was immunohistochemically investigated for Claudin-1 (a membrane-tight junction protein and important for the sealing of the paracellular cleft in epithelial and endothelial cells) expression in order to assess the possible significance of Claudin-1 expression in prostate cancer. Results recognized a unique role for Claudin-1 in prostate cancer. Moreover, in a fraction of prostate cancers, the protein was overexpressed and raised Claudin-1 expression levels prognosticated a favorable prognosis in ERG-positive cancer.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay